Zhejiang Supor (002032.SZ) granted 1.043 million stock options to 57 incentive recipients.
Zhejiang Supor (002032.SZ) announced that the conditions for granting stock options under the company's 2026 Stock Option Incentive Plan (Draft) have been fulfilled. The board of directors agreed to grant 1.043 million stock options to 57 incentive recipients, with the grant date being September 22, 2026, and the exercise price of the granted stock options set at RMB 31.21 per share.
Zhejiang Supor (002032.SZ) announced that the conditions for granting stock options under the company's 2026 Stock Option Incentive Plan (Draft) have been fulfilled. The board of directors agreed to grant 1.043 million stock options to 57 incentive recipients, with the grant date being September 22, 2026, and the exercise price of the granted stock options at RMB 31.21 per share.
Related Articles
AI infrastructure supplier Accelevation (ACCV.US) races toward U.S. IPO, valued at up to $5.37 billion.
SF INTRA-CITY (09699) repurchased 896,000 shares for HK$7.9905 million on September 22.
Changchun High-Tech Industry (000661.SZ): Clinical trial application for the recombinant human anti-respiratory syncytial virus monoclonal antibody injection combination product has been accepted.
AI infrastructure supplier Accelevation (ACCV.US) races toward U.S. IPO, valued at up to $5.37 billion.
SF INTRA-CITY (09699) repurchased 896,000 shares for HK$7.9905 million on September 22.
Changchun High-Tech Industry (000661.SZ): Clinical trial application for the recombinant human anti-respiratory syncytial virus monoclonal antibody injection combination product has been accepted.
